Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk

In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #621: Whole-Body MRI for Cancer Screening: Many findings, little benefit

In episode 621, Tina, James and Mike K talk about the evidence around whole-body MRIs. We discuss how many abnormalities are found, how many cancers are actually found, and finally…
Listen 0.5 credits available

BS Medicine Episode #620: Back on the stand: Colchicine for secondary cardiovascular prevention update

In episode 620, Mike K and James bring back Danielle Perry, this time to talk about the evidence around the use of colchicine for secondary cardiovascular prevention. There are some…
Listen 0.5 credits available

In the Clinic Episode 58: Neck Pain

In this episode of In the Clinic, the team discusses John Painica, a 52-year-old man presenting with neck pain.
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Dr. Tina Korownyk

Speakers do not have any conflicts of interest to declare.